Violich Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.3M Sell
87,990
-3,548
-4% -$827K 2.43% 11
2026
Q1
$22.4M Sell
91,538
-2,500
-3% -$582K 2.62% 10
2025
Q4
$19.5M Sell
94,038
-1,698
-2% -$336K 2.17% 12
2025
Q3
$17.8M Buy
95,736
+7,400
+8% +$1.27M 2.11% 10
2025
Q2
$13.5M Sell
88,336
-12,404
-12% -$1.91M 1.9% 12
2025
Q1
$16.7M Buy
100,740
+523
+0.5% +$81.8K 2.25% 11
2024
Q4
$14.5M Buy
100,217
+2,539
+3% +$393K 1.89% 13
2024
Q3
$15.8M Buy
97,678
+557
+0.6% +$88.7K 2.06% 12
2024
Q2
$14.2M Buy
97,121
+385
+0.4% +$57.3K 1.92% 13
2024
Q1
$15.3M Buy
96,736
+4,162
+4% +$662K 2.19% 12
2023
Q4
$14.5M Sell
92,574
-1,760
-2% -$270K 2.36% 13
2023
Q3
$14.7M Sell
94,334
-10,949
-10% -$1.81M 2.51% 12
2023
Q2
$17.4M Sell
105,283
-1,220
-1% -$197K 2.81% 8
2023
Q1
$16.5M Hold
106,503
2.81% 11
2022
Q4
$18.8M Sell
106,503
-1,014
-0.9% -$175K 3.34% 10
2022
Q3
$17.6M Buy
107,517
+29
+0% +$4.91K 3.31% 9
2022
Q2
$19.1M Buy
107,488
+174
+0.2% +$31K 3.34% 8
2022
Q1
$19M Sell
107,314
-397
-0.4% -$67.6K 2.81% 9
2021
Q4
$18.4M Sell
107,711
-1,273
-1% -$208K 2.65% 9
2021
Q3
$17.6M Buy
108,984
+1,960
+2% +$334K 2.83% 9
2021
Q2
$17.6M Sell
107,024
-1,740
-2% -$288K 2.96% 8
2021
Q1
$17.9M Buy
108,764
+2,025
+2% +$328K 3.22% 8
2020
Q4
$16.8M Buy
106,739
+5
+0% +$738 3.25% 8
2020
Q3
$15.9M Sell
106,734
-7,640
-7% -$1.13M 3.35% 7
2020
Q2
$16.1M Buy
114,374
+825
+0.7% +$120K 3.52% 8
2020
Q1
$14.9M Buy
113,549
+190
+0.2% +$27K 3.99% 8
2019
Q4
$16.5M Buy
113,359
+975
+0.9% +$132K 3.61% 8
2019
Q3
$14.5M Sell
112,384
-800
-0.7% -$105K 3.5% 8
2019
Q2
$15.8M Sell
113,184
-1,420
-1% -$197K 3.88% 7
2019
Q1
$16M Buy
114,604
+214
+0.2% +$28.7K 4.06% 7
2018
Q4
$14.8M Sell
114,390
-640
-0.6% -$89.3K 4.19% 7
2018
Q3
$15.9M Buy
115,030
+1,290
+1% +$171K 3.63% 7
2018
Q2
$13.8M Buy
113,740
+1,580
+1% +$197K 3.47% 7
2018
Q1
$14.4M Sell
112,160
-1,330
-1% -$180K 3.85% 7
2017
Q4
$15.9M Buy
113,490
+950
+0.8% +$132K 4.04% 5
2017
Q3
$14.6M Sell
112,540
-672
-0.6% -$89.1K 3.99% 6
2017
Q2
$15M Buy
113,212
+50
+0% +$6.38K 4.37% 5
2017
Q1
$14.1M Sell
113,162
-300
-0.3% -$35.8K 4.26% 5
2016
Q4
$12.9M Buy
113,462
+359
+0.3% +$41.5K 3.97% 5
2016
Q3
$13.4M Sell
113,103
-1,050
-0.9% -$127K 4.68% 4
2016
Q2
$13.8M Sell
114,153
-1,150
-1% -$131K 4.37% 2
2016
Q1
$12.5M Sell
115,303
-6,603
-5% -$684K 4.01% 5
2015
Q4
$12.5M Sell
121,906
-5,153
-4% -$518K 4.15% 6
2015
Q3
$11.9M Buy
127,059
+800
+0.6% +$77.4K 4.15% 5
2015
Q2
$12.3M Sell
126,259
-750
-0.6% -$75.1K 4.02% 5
2015
Q1
$12.8M Buy
127,009
+660
+0.5% +$67.1K 4.15% 4
2014
Q4
$13.2M Buy
126,349
+5,074
+4% +$535K 4.2% 4
2014
Q3
$12.9M Buy
121,275
+4,855
+4% +$504K 4.21% 4
2014
Q2
$12.2M Buy
116,420
+100
+0.1% +$10.1K 4.07% 4
2014
Q1
$11.4M Buy
116,320
+400
+0.3% +$37.1K 3.98% 3
2013
Q4
$10.6M Sell
115,920
-545
-0.5% -$50.2K 3.81% 5
2013
Q3
$10.1M Buy
116,465
+300
+0.3% +$26.9K 3.94% 3
2013
Q2
$9.97M Buy
+116,165
New +$9.86M 4.04% 3

Other funds holding JNJ

Violich Capital Management's JNJ Position: Q2 2026 in Review

Violich Capital Management reduced its Johnson & Johnson (JNJ) stake by 3.9% in Q2 2026, selling an estimated $827K and leaving 87,990 shares worth $22.3M. The position accounts for 2.43% of the portfolio, ranked #11.

Violich Capital Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $22.4M in Q1 2026. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Violich Capital Management held 87,990 shares of Johnson & Johnson worth $22.3M as of Q2 2026.
  • Violich Capital Management sold 3,548 Johnson & Johnson shares in Q2 2026, an estimated $827K.
  • Johnson & Johnson made up 2.43% of Violich Capital Management's portfolio in Q2 2026, its #11 holding.
  • Violich Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Violich Capital Management's Johnson & Johnson position peaked at $22.4M in Q1 2026.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Violich Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.